Sabalis serrulatae fructus Other names: Serenoa repens Saw palmetto

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
G04CX02 Sabalis serrulatae fructus G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CX Other drugs used in benign prostatic hypertrophy
Discover more medicines within G04CX02

External identifiers

DrugBank Drug: DB14360
UNII Identifier: 487DXM62F2
SERENOA REPENS WHOLE

Medicines

Sabalis serrulatae fructus is an active ingredient of these brands:

Croatia (HR)

Finland (FI)

France (FR)

  • PERMIXON as Serenoa repens extract
  • PRODINAN as Serenoa repens lipidosterolic extract

Germany (DE)

Israel (IL)

Lithuania (LT)

Poland (PL)

Romania (RO)

Spain (ES)

  • SEREPROSTAT as Serenoa repens lipido-sterolic extract
  • SEREQUR as Serenoa repens lipido-sterolic extract

Tunisia (TN)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.